Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.190 | 2.020 | 0.830 |
Shares | 99.980 | 99.980 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.502 | 15.343 |
Price to Book | 2.927 | 2.080 |
Price to Sales | 2.072 | 1.198 |
Price to Cash Flow | 12.129 | 9.434 |
Dividend Yield | 1.729 | 2.602 |
5 Years Earnings Growth | 11.428 | 13.401 |
Name | Net % | Category Average |
---|---|---|
Technology | 28.190 | 19.928 |
Healthcare | 21.500 | 12.406 |
Industrials | 20.870 | 25.190 |
Financial Services | 11.520 | 10.991 |
Consumer Cyclical | 6.830 | 14.103 |
Basic Materials | 5.110 | 6.449 |
Communication Services | 3.570 | 5.270 |
Consumer Defensive | 2.410 | 5.351 |
Number of long holdings: 71
Number of short holdings: 5
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Boku | USU7744C1063 | 4.62 | 180.00 | 0.00% | |
Teqnion | SE0012308088 | 3.69 | 193.2000 | -0.62% | |
JDC Group | DE000A0B9N37 | 3.43 | 21.30 | +1.43% | |
SDI Group | GB00B3FBWW43 | 3.26 | 59.00 | +1.72% | |
Marlowe | GB00BD8SLV43 | 3.13 | 350.00 | +4.01% | |
Diploma | GB0001826634 | 2.95 | 4,288.00 | +0.70% | |
Dermapharm | DE000A2GS5D8 | 2.72 | 31.05 | -0.48% | |
JTC | JE00BF4X3P53 | 2.71 | 1,028.00 | 0.00% | |
Robertet | FR0000039091 | 2.51 | 933.00 | +0.21% | |
GB Group | GB0006870611 | 2.49 | 343.40 | +0.94% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
NN Duurzaam Aandelen Fonds P | 848.74M | 7.79 | 10.52 | 12.85 | ||
NL0006311805 | 736.77M | -12.25 | 8.26 | 9.47 | ||
NL0000289858 | 424.15M | -4.48 | 7.06 | 8.98 | ||
NL0006311847 | 437.15M | -19.25 | -3.23 | 5.06 | ||
NN Dynamic Mix Fund IV P | 311.77M | 3.71 | 5.15 | 7.45 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review